Anesthesia and the child with asthma

Paediatric Anaesthesia

Volumn 15, Issue 6, 2005, Pages 446-454

  Doherty, Gary M ^a,b,c   Chisakuta, Anthony ^b   Crean, Peter ^b   Shields, Michael D ^a,b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL BELFAST HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c Institute of Clinical Sciences B   (United Kingdom)

Author keywords

Anesthesia; Asthma; Pathophysiology; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; AMINOPHYLLINE; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ATRACURIUM; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHLORPHENIRAMINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DICLOFENAC; EMLA; FENTANYL; FORMOTEROL; HALOTHANE; HYDROCORTISONE; IBUPROFEN; INHALATION ANESTHETIC AGENT; IPRATROPIUM BROMIDE; ISOFLURANE; KETAMINE; LATEX; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIDOCAINE; LONG ACTING DRUG; MAGNESIUM; METHYLPREDNISOLONE; MIDAZOLAM; MORPHINE; NEUROMUSCULAR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PREDNISOLONE; PROPOFOL; RANITIDINE; SALBUTAMOL; SALMETEROL; SEVOFLURANE; SUXAMETHONIUM; TETRACAINE;

ADRENAL CORTEX INSUFFICIENCY; AIRWAY IRRITATION; ALLERGY; ANAPHYLAXIS; ANESTHESIA COMPLICATION; ANESTHESIA INDUCTION; ASTHMA; BRONCHOSPASM; BRONCHUS SECRETION; CHILD; CHILDHOOD DISEASE; DISEASE CONTROL; DISEASE MARKER; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SAFETY; EMERGENCY TREATMENT; HEART ARRHYTHMIA; HUMAN; IMAGING AND DISPLAY; INCREASED AIRWAY SECRETION; INFLAMMATION; INHALATION ANESTHESIA; INTRAVENOUS ANESTHESIA; LUNG FUNCTION TEST; PEDIATRIC ANESTHESIA; POSTOPERATIVE CARE; PREMEDICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INTUBATION; REVIEW; WHEEZING;

ANESTHESIA; ANESTHESIA, INHALATION; ANESTHESIA, INTRAVENOUS; ASTHMA; CHILD; HUMANS; INTUBATION, INTRATRACHEAL; POSTOPERATIVE CARE; PREANESTHETIC MEDICATION; PREOPERATIVE CARE; RESPIRATORY FUNCTION TESTS;

EID: 20444449392     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2005.01602.x     Document Type: Review

References (101)

1. Burr ML, Butland BK, King S et al. Changes in asthma prevalence: two surveys 15 years apart. Arch Dis Child 1989; 64: 1452-1456.
2. Kuehni CE, Davis A, Brooke AM et al. Are all wheezing disorders in very young (preschool) children increasing in prevalence? Lancet 2001; 357: 1821-1825.
3. Toelle BG, Ng K, Belousova E et al. Prevalence of asthma and allergy in schoolchildren in Belmont, Australia: three cross sectional surveys over 20 years. BMJ 2004; 328: 386-387.
4. Brennan LJ. Modern day-case anaesthesia for children. Br J Anaesth 1999; 83: 91-103.
5. Warner DO, Warner MA, Barnes RD et al. Perioperative respiratory complications in patients with asthma. Anesthesiology 1996; 85: 460-467.
6. Anderson HR, Ruggles R, Strachan DP et al. Trends in prevalence of symptoms of asthma, hay fever, and eczema in 12-14 year olds in the British Isles, 1995-2002: questionnaire survey. BMJ 2004; 328: 1052-1053.
7. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998; 351: 1225-1232.
8. Sears MR, Greene JM, Willan AR et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003; 349: 1414-1422.
9. Strachan DP, Butland BK, Anderson HR. Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort. BMJ 1996; 312: 1195-1199.
10. Martinez FD. Development of wheezing disorders and asthma in preschool children. Pediatrics 2002; 109: 362-367.
11. Stein RT, Holberg CJ, Morgan WJ et al. Peak flow variability, methacholine responsiveness and atopy as markers for detecting different wheezing phenotypes in childhood. Thorax 1997; 52: 946-952.
12. Taussig LM, Wright AL, Holberg CJ et al. Tucson Children's Respiratory Study: 1980 to present. J Allergy Clin Immunol 2003; 111: 661-675.
13. Bousquet J, Chanez P, Lacoste JY et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033-1039.
14. Ennis M. Neutrophils in asthma pathophysiology. Curr Allergy Asthma Rep 2003; 3: 159-165.
15. Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001; 119: 1329-1336.
16. Cokugras H, Akcakaya N, Seckin I et al. Ultrastructural examination of bronchial biopsy specimens from children with moderate asthma. Thorax 2001; 56: 25-29.
17. Pohunek P, Roche WR, Tarzikova J et al. Eosinophilic inflammation in the bronchial mucosa in children with bronchial asthma. Eur Respir J 2000; 11(Suppl. 25): 160.
18. Davies DE, Wicks J, Powell RM et al. Airway remodeling in asthma: new insights. J Allergy Clin Immunol 2003; 111: 215-225.
19. Bousquet J, Jeffery PK, Busse WW et al. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000; 161: 1720-1745.
20. British Thoracic Society and Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. (Revised edition, April 2004) http://www.sign.ac.uk
21. de Jongste JC, Shields MD. Cough 2: chronic cough in children. Thorax 2003; 58: 998-1003.
22. Thomson F, Masters IB, Chang AB. Persistent cough in children and the overuse of medications. J Paediatr Child Health 2002; 38: 578-581.
23. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma (update on selected topics 2002), 02-5074, 1-6-2003. Bethesda, MD, National Institute of Health.
24. McKenzie SA, Bush A. Difficult asthma in children. Thorax 2002; 57: 915-916.
25. Balfour-Lynn I. Difficult asthma: beyond the guidelines. Arch Dis Child 1999; 80: 201-206.
26. Plaza V, Serrano J, Picado C et al. Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma. Eur Respir J 2002; 19: 846-852.
27. James A, King G. The computed tomographic scan: a new tool to monitor asthma treatment? Am J Med 2004; 116: 775-777.
28. Takemura M, Niimi A, Minakuchi M et al. Bronchial dilatation in asthma: relation to clinical and sputum indices. Chest 2004; 125: 1352-1358.
29. De Boeck K, Willems T, Van Gysel D et al. Outcome after right middle lobe syndrome. Chest 1995; 108: 150-152.
30. Eastham KM, Fall AJ, Mitchell L et al. The need to redefine non-cystic fibrosis bronchiectasis in childhood. Thorax 2004; 59: 324-327.
31. Hughes JM, Rimmer SJ, Salome CM et al. Eosinophilia, interleukin-5, and rumour necrosis factor-alpha in asthmatic children. Allergy 2001; 56: 412-418.
32. Fitch PS, Brown V, Schock BC et al. Serum eosinophil cationic protein (ECP): reference values in healthy nonatopic children. Allergy 1999; 54: 1199-1203.
33. Kips JC, Pauwels RA. Serum eosinophil cationic protein in asthma: what does it mean? Clin Exp Allergy 1998; 28: 1-3.
34. Shields MD, Brown V, Stevenson EC et al. Serum eosinophilic cationic protein and blood eosinophil counts for the prediction of the presence of airways inflammation in children with wheezing. Clin Exp Allergy 1999; 29: 1382-1389.
35. Severien C, Artlich A, Jonas S et al. Urinary excretion of leukotriene E4 and eosinophil protein X in children with atopic asthma. Eur Respir J 2000; 16: 588-592.
36. Strunk RC, Szefler SJ, Phillips BR et al. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J Allergy Clin Immunol 2003; 112: 883-892.
37. Lim S, Jatakanon A, Meah S et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma. Thorax 2000; 55: 184-188.
38. van den Toorn LM, Prins JB, Overbeek SE et al. Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness. Am J Respir Crit Care Med 2000; 162: 953-957.
39. Warke TJ, Fitch PS, Brown V et al. Exhaled nitric oxide correlates with airway eosinophils in childhood asthma. Thorax 2002; 57: 383-387.
40. Warke TJ, Fitch PS, Brown V et al. Outgrown asthma does not mean no airways inflammation. Eur Respir J 2002; 19: 284-287.
41. Bruce C, Yates DH, Thomas PS. Caffeine decreases exhaled nitric oxide. Thorax 2002; 57: 361-363.
42. Warke TJ, Shields MD, Finnegan J et al. Caffeine and exhaled nitric oxide. Thorax 2003; 58: 281.
43. Hepner DL. Sudden bronchospasm on intubation: latex anaphylaxis? J Clin Anesth 2000; 12: 162-166.
44. Kil N, Zhu JF, VanWagnen C et al. The effects of midazolam on pediatric patients with asthma. Pediatr Dent 2003; 25: 137-142.
45. Wu RS, Wu KC, Wong TK et al. Effects of fenoterol and ipratropium on respiratory resistance of asthmatics after tracheal intubation. Br J Anaesth 2000; 84: 358-362.
46. Scalfaro P, Sly PD, Sims C et al. Salbutamol prevents the increase of respiratory resistance caused by tracheal intubation during sevoflurane anesthesia in asthmatic children. Anesth Analg 2001; 93: 898-902.
47. Mitsuta K, Shimoda T, Fukushima C et al. Preoperative steroid therapy inhibits cytokine production in the lung parenchyma in asthmatic patients. Chest 2001; 120: 1175-1183.
48. Black AE. Medical assessment of the paediatric patient. Br J Anaesth 1999; 83: 3-15.
49. Dunlop KA, Carson DJ, Shields MD. Hypoglycemia due to adrenal suppression secondary to high-dose nebulized corticosteroid. Pediatr Pulmonol 2002; 34: 85-86.
50. Nakamura H, Matsuse H, Obase Y et al. Clinical evaluation of anaphylactic reactions to intravenous corticosteroids in adult asthmatics. Respiration 2002; 69: 309-313.
51. Groeben H, Schlicht M, Stieglitz S et al. Both local anesthetics and salbutamol pretreatment affect reflex bronchoconstriction in volunteers with asthma undergoing awake fiberoptic intubation. Anesthesiology 2002; 97: 1445-1450.
52. Groeben H, Grosswendt T, Silvanus M et al. Lidocaine inhalation for local anaesthesia and attenuation of bronchial hyper-reactivity with least airway irritation. Effect of three different dose regimens. Eur J Anaesthesiol 2000; 17: 672-679.
53. Groeben H, Silvanus MT, Beste M et al. Combined lidocaine and salbutamol inhalation for airway anesthesia markedly protects against reflex bronchoconstriction. Chest 2000; 118: 509-515.
54. Parker JF, Vats A, Bauer G. EMLA toxicity after application for allergy skin testing. Pediatrics 2004; 113: 410-411.
55. Mancini AJ. Skin. Pediatrics 2004; 113: 1114-1119.
56. Pradal M, Vialet R, Soula F et al. The risk of anesthesia in the asthmatic child. Pediatr Pulmonol Suppl 1995; 11: 51-52.
57. Howton JC, Rose J, Duffy S et al. Randomized, double-blind, placebo-controlled trial of intravenous ketamine in acute asthma. Ann Emerg Med 1996; 27: 170-175.
58. Youssef-Ahmed MZ, Silver P, Nimkoff L et al. Continuous infusion of ketamine in mechanically ventilated children with refractoiy bronchospasm. Intensive Care Med 1996; 22: 972-976.
59. Pizov R, Brown RH, Weiss YS et al. Wheezing during induction of general anesthesia in patients with and without asthma. A randomized, blinded trial. Anesthesiology 1995; 82: 1111-1116.
60. Wu RSC, Wu KC, Sum DCW et al. Comparative effects of thiopentone and propofol on respiratory resistance after tracheal intubation. Br J Anaesth 1996; 77: 735-738.
61. Hirota K, Sato T, Hashimoto Y et al. Relaxant effect of propofol on the airway in dogs. Br J Anaesth 1999; 83: 292-295.
62. Nishiyama T, Hanaoka K. Propofol-induced broncho-constriction: two case reports. Anesth Analg 2001; 93: 645-646.
63. Werner HA. Status asthmaticus in children: a review. Chest 2001; 119: 1913-1929.
64. Bishop MJ, Rooke GA. Sevoflurane for patients with asthma. Anesth Analg 2000; 91: 245-246.
65. Pappas AL, Sukhani R, Lurie J et al. Severity of airway hyperreactivity associated with laryngeal mask airway removal: correlation with volatile anesthetic choice and depth of anesthesia. J Clin Anesth 2001; 13: 498-503.
66. Blayney MR, Malins AF, Cooper GM. Cardiac arrhythmias in children during outpatient general anaesthesia for dentistry: a prospective randomised trial. Lancet 1999; 354: 1864-1866.
67. Tait AR, Pandit UA, Voepel-Lewis T et al. Use of the laryngeal mask airway in children with upper respiratory tract infections: a comparison with endotracheal intubation. Anesth Analg 1998; 86: 706-711.
68. Cohen MM, Cameron CB. Should you cancel the operation when a child has an upper respiratory tract infection? Anesth Analg 1991; 72: 282-288.
69. Parnis SJ, Barker DS, van der Walt JH. Clinical predictors of anaesthetic complications in children with respiratory tract infections. Paediatr Anaesth 2001; 11: 29-40.
70. Roberts G, Newsom D, Gomez K et al. Intravenous salbutamol bolus compared with an aminophylline infusion in children with severe asthma: a randomised controlled trial. Thorax 2003; 58: 306-310.
71. South M. Second line treatment for severe acute childhood asthma. Thorax 2003; 58: 284-285.
72. Redden RJ. Possible theophylline toxicity during anesthesia. Anesth Prog 1996; 43: 67-72.
73. Richards W, Thompson J, Lewis G et al. Cardiac arrest associated with halothane anesthesia in a patient receiving theophylline. Ann Allergy 1988; 61: 83-84.
74. Molfino NA, Nannini LJ, Martelli AN et al. Respiratory arrest in near-fatal asthma [see Comments]. N Engl J Med 1991; 324: 285-288.
75. Laxenaire MC, Mertes PM. Anaphvlaxis during anaesthesia. Results of a two-year survey in France. Br J Anaesth 2001; 87: 549-558.
76. Holzman RS. Clinical management of latex-allergic children. Anesth Analg 1997; 85: 529-533.
77. Kelly KJ, Pearson ML, Kurup VP et al. A cluster of anaphylactic reactions in children with spina bifida during general anesthesia: epidemiologic features, risk factors, and latex hypersensitivity. J Allergy Clin Immunol 1994; 94: 53-61.
78. Kwittken PL, Sweinberg SK, Campbell DE et al. Latex hypersensitivity in children: clinical presentation and detection of latex-specific immunoglobulin E. Pediatrics 1995; 95: 693-699.
79. Dakin MJ, Yentis SM. Latex allergy: a strategy for management. Anaesthesia 1998; 53: 774-781.
80. Advanced Life Support Group. Advanced Paediatric Life Support: The Practical Approach, 3rd edn. London: BMJ Books.
81. Association of Anaesthetists of Great Britain and Ireland and British Society of Allergy and Clinical Immunology. Suspected Anaphylactic Reactions Associated with Anaesthesia.
82. Zora JA, Zimmerman D, Carey TL et al. Hypothalamic-pituitary-adrenal axis suppression after short-term, high-dose glucocorticoid therapy in children with asthma. J Allergy Clin Immunol 1986; 77: 9-13.
83. Ducharme FM, Chabot G, Polychronakos C et al. Safety profile of frequent short courses of oral glucocorticoids in acute pediatric asthma: impact on bone metabolism, bone density, and adrenal function. Pediatrics 2003; 111: 376-383.
84. Dolan LM, Kesarwala HH, Holroyde JC et al. Short-term, high-dose, systemic steroids in children with asthma: the effect on the hypothalamic-pituitary-adrenal axis. J Allergy Clin Immunol 1987; 80: 81-87.
85. Axelrod L. Perioperative management of patients treated with glucocorticoids. Endocrinol Metab Clin North Am 2003; 32: 367-383.
86. Todd GRG, Acerini CL, Ross-Russell R et al. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 2002; 87: 457-461.
87. Dunlop KA, Carson DJ, Steen HJ et al. Monitoring growth in asthmatic children treated with high dose inhaled glucocorticoids does not predict adrenal suppression. Arch Dis Child 2004; 89: 713-716.
88. Committee on Safety of Medicines. Inhaled corticosteroids and adrenal suppression in children. Curr Probl Pharmacovigil 2002; 28: 7.
89. Committee on Safety of Medicines. Withdrawal of systemic corticosteroids. Curr Prob Pharmacovigil 1998; 24: 5-6.
90. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004; 328: 434-440.
91. Lesko SM. The safety of ibuprofen suspension in children, Int J Clin Pract Suppl 2003; 50-53.
92. Lesko SM, Louik C, Vezina RM et al. Asthma morbidity after the short-term use of ibuprofen in children. Pediatrics 2002; 109: E20.
93. Goraya JS, Virdi VS. To the editor: exacerbation of asthma by ibuprofen in a very young child. Pediatr Pulmonol 2001; 32: 262.
94. Short JA, Barr CA, Palmer CD et al. Use of diclofenac in children with asthma. Anaesthesia 2000; 55: 334-337.
95. Gupta D, Aggarwal AN, Aggarwal PN et al. Near fatal asthma following ingestion of diclofenac sodium tablet. J Assoc Physicians India 2000; 48: 258-259.
96. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE investigators. European network on aspirin-induced asthma. Eur Respir J 2000; 16: 432-436.
97. Vally H, Taylor ML, Thompson PJ. The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients. Thorax 2002; 57: 569-574.
98. May HA, Smyth RL, Romer HC et al. Effect of anaesthesia on lung function in children with asthma. Br J Anaesth 1996; 77: 200-202.
99. Petrillo TM, Fortenberry JD, Linzer JF et al. Emergency department use of ketamine in pediatric status asthmaticus. J Asthma 2001; 38: 657-664.
100. Royal College of Paediatrics and Child Health, Neonatal and Paediatric Pharmacists Group. Medicines for Children, 2nd edn. London: RCPCH Publications Ltd., 2003.
101. Joint Formulary Committee. British National Formulary, 48 edn. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2004.